Since receiving FDA 510(k) clearance in June for our ENFit® Low Dose Tip design, NeoMed, Inc. has received commitments for immediate conversion from over 60 hospitals nationwide to transition to our NeoConnect Pharmacy and Enteral ENFit solutions. Conversions are underway. The first hospital transition is a leading Children’s Hospital, likely the first acute care facility in the United States to complete a transition to ENFit. NeoMed’s charter ENFit customer will be utilizing the NeoConnect solution as an integrated single-source solution for both Pharmacy and PICU/NICU.
Internationally, clinicians at the first known European hospital using the NeoMed NeoConnect™ system (syringes, feeding tubes, and extension sets) have said “[We] are very happy with the NeoConnect range and are extremely impressed by the level of support and training we have received/are receiving.”
In the February 2016 GEDSA Position Statement, “GEDSA and its supporting organizations strongly suggest [facilities] work with…supplier representative[s] and distributor network[s] to understand their specific plans for conversion.” As a result of our collaborative focus, NeoMed has earned the support of many early ENFit adopters. These efforts will allow us to share their collective clinical experiences with partners across the world. Important transition considerations include staff inservicing, medication dosing processes, feeding tube maintenance protocols, as well as clinical patient care procedures.
Please consult your local NeoMed Representative for further details.
NM-SMM-012 Rev 1